Physician

Todd A Berger, MD

According to 2025 Medicare claims, Todd Berger, MD (NPI: 1205836418) practices ophthalmology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Manatee, FL. This provider's primary affiliated billing organization is EYE ASSOCIATES OF MANATEE, LLP (NPI: 1366483851; TIN: 650105559) and primary practice location at 34209-5531.

Berger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 39,642 HCPCS/CPT codes, and received $2,389,398 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 172 prescription claims across 53 beneficiaries totaling $11,445 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 3 records totaling $123. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $3,404,212 to $2,389,398. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,159 and ending at $11,445. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $3,404,212 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,220,700 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,930,625 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,528,074 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,552,115 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,312,520 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,708,527 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,486,729 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,578,433 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,389,398 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201590717,179$3,404,212
201678816,284$3,220,700
201771214,649$2,930,625
201861411,965$2,528,074
201964011,963$2,552,115
202053510,603$2,312,520
20214328,636$1,708,527
20224307,441$1,486,729
202340314,101$1,578,433
202443539,642$2,389,398

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$49K$98K2015 Drug cost: $19,159 (USD; Tot_Drug_Cst)2016 Drug cost: $29,368 (USD; Tot_Drug_Cst)2017 Drug cost: $22,588 (USD; Tot_Drug_Cst)2018 Drug cost: $20,313 (USD; Tot_Drug_Cst)2019 Drug cost: $23,734 (USD; Tot_Drug_Cst)2020 Drug cost: $38,361 (USD; Tot_Drug_Cst)2021 Drug cost: $35,315 (USD; Tot_Drug_Cst)2022 Drug cost: $97,544 (USD; Tot_Drug_Cst)2023 Drug cost: $16,960 (USD; Tot_Drug_Cst)2024 Drug cost: $11,445 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201580169$19,159
201692209$29,368
201786195$22,588
201884200$20,313
201977175$23,734
202089247$38,361
202180228$35,315
202279230$97,544
202349175$16,960
202453172$11,445

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system325489$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more149167$93
67028Injection of drug into eye2011,391$91
92134Imaging of retina4051,256$30
92250Photography of the retina238395$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium14392$4,931
Prednisolone AcetatePrednisolone Acetate451,471$2,023
Brimonidine TartrateBrimonidine Tartrate191,023$862
Ketorolac TromethamineKetorolac Tromethamine28931$632
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat271,393$138

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$123Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Todd A. Berger, MD?

Tedicare shows public-source Medicare data for Todd A. Berger, MD (NPI 1205836418), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd A. Berger, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Todd A. Berger, MD?

Todd A. Berger, MD is linked to EYE ASSOCIATES OF MANATEE, LLP (billing NPI 1366483851) in the available physician profile data.

Does Todd A. Berger, MD have Open Payments data?

Todd A. Berger, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.